pentobarbital decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Coadministration of CYP3A4 inducers may possibly reduce sufentanil amounts and efficacy, quite possibly precipitating withdrawal syndrome in individuals who've designed physical dependence to sufentanil. Disconti